Long-term Outcomes with Everolimus Following Calcineurin Inhibitor Withdrawal: Data from the H2304 and PROTECT Extension Studies

被引:0
|
作者
Fischer, L. [1 ,2 ]
Fung, J. [1 ]
Metselaar, H. J. [1 ]
Kaiser, G. [1 ,2 ]
Schemmer, P. [2 ]
Neuhaus, P. [2 ]
Dong, G. [3 ]
Lopez, P. [4 ]
Bernhardt, P. [4 ]
Schlitt, H. J. [2 ]
机构
[1] H2304 Study Grp, Hamburg, Germany
[2] PROTECT Study Grp, Hamburg, Germany
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
O-26
引用
收藏
页码:S88 / S88
页数:1
相关论文
共 50 条
  • [21] Optimizing Renal Function through Minimizing Calcineurin Inhibitor Exposure - Long term Results from a Calcineurin Inhibitor-Everolimus Based Immunosuppression
    Zweytick, B.
    Ghanim, B.
    Sillipp, J.
    Boehmig, G.
    Jaksch, P.
    Klepetko, W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S15 - S16
  • [22] CONVERSION FROM CALCINEURIN INHIBITOR-BASED TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS: LONG-TERM OUTCOME
    Dayangac, Murat
    TRANSPLANT INTERNATIONAL, 2017, 30 : 363 - 363
  • [23] Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR study
    van Hooff, Maria C.
    de Veer, Rozanne C.
    Karam, Vincent
    Adam, Rene
    Taimr, Pavel
    Polak, Wojciech G.
    Pashtoun, Hasina
    Murad, Sarwa Darwish
    Corpechot, Christophe
    Mirza, Darius
    Heneghan, Michael
    Lodge, Peter
    Oniscu, Gabriel C.
    Thorburn, Douglas
    Allison, Michael
    Metselaar, Herold J.
    den Hoed, Caroline M.
    van der Meer, Adriaan J.
    JHEP REPORTS, 2024, 6 (08)
  • [24] Outcomes of Switching to Belatacept from a Calcineurin Inhibitor in Kidney Transplant Recipients: 3 Year Results from the Long-Term Extension of a Phase II Study.
    Grinyo, J.
    Rial, M.
    Alberu, J.
    Steinberg, S.
    Manfro, R.
    Nainan, G.
    Vincenti, F.
    Jones-Burton, C.
    Kamar, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 182 - 182
  • [25] Long-Term Outcomes Following a Calcineurin Sparing Protocol After Renal Transplantation.
    Soliman, K.
    Mogadam, E.
    Laftavi, M.
    Patel, S.
    Feng, L.
    Said, M.
    Pankewycz, O.
    TRANSPLANTATION, 2014, 98 : 540 - 540
  • [26] Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study
    Holdaas, Hallvard
    Rostaing, Lionel
    Seron, Daniel
    Cole, Edward
    Chapman, Jeremy
    Fellstrom, Bengt
    Strom, Erik H.
    Jardine, Alan
    Midtvedt, Karsten
    Machein, Uwe
    Ulbricht, Bettina
    Karpov, Alexander
    O'Connell, Philip J.
    TRANSPLANTATION, 2011, 92 (04) : 410 - 418
  • [27] Long-Term Outcomes After Liver Transplantation (tx) with Everolimus (EVR) and Mycophenolic Acid (MPA) in a Calcineurin Inhibitor-Free Regimen: The CERTITUDE Trial
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Calmus, Y.
    Di Giambattista, F.
    Conti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 392 - 392
  • [28] Early Steroid Withdrawal with a Sirolimus - and Mycophenolate-Based Calcineurin Inhibitor Minimization Regimen: Long-Term Results
    Conti, D. J.
    Conti, B. J.
    Dellehunt, R.
    Chandolias, N.
    Siparsky, N.
    Gallichio, M. H.
    TRANSPLANTATION, 2012, 94 (10) : 979 - 979
  • [29] Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation
    Iwahara, Naoya
    Hotta, Kiyohiko
    Hirose, Takayuki
    Shinohara, Nobuo
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (04) : 803 - 808
  • [30] LONG-TERM AUSTRALIAN BIORESORBABLE SCAFFOLD OUTCOMES FOLLOWING WITHDRAWAL FROM MARKET: A REPORT FROM THE VICTORIAN CARDIAC OUTCOMES REGISTRY
    Dawson, Luke
    Dinh, Diem
    Montalto, Stephanie
    Brennan, Angela
    Carruthers, Harriet
    Doyle, Janine
    Dick, Ron
    Gooley, Robert
    Gutman, Jack
    Duffy, Stephen
    Lefkovits, Jeffrey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1409 - 1409